chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Initial report received from a health care professional on 02 September 2010. A female patient (age not reported) received on an unknown date last year, an injection (route and site not provided) of FLUZONE SV, lot number not reported. The patient following vaccination experienced throat constriction and "other anaphylactic reactions". The patient had received several previous FLUZONE vaccines and did not have any reaction. The patient reported that she was not allergic to eggs. Any further information was declined to be provided about the patient or patient's reaction. The information had already been filed with VAERS last year and did not want any further contact for this situation. the outcome was not reported. Documents held by sender: None.
received shot #1 of Shingrix/  October 2020/not yet gotten the second shot/6 month window has passed; This case was reported by a consumer via call center representative and described the occurrence of incomplete course of vaccination in a 69-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose of Shingrix in October 2020 in an unspecified arm intramusclarly).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: This case was reported by patient himself. The age at vaccination was not applicable to this report. Till the time of reporting, the patient did not receive 2nd dose of Shingrix and the 6 months window had passed, which led to incomplete course of vaccination. The VAERS details were reported for 1st dose of Shingrix. The reporter consented to follow up.
Fast heartbreak/ fast heart rate; Diarrhea; Burning in a chest/ got constant burning in the chest; Face and arms and chest turning red; Skin feeling hot; Got a little of a fever 98. 7; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (Fast heartbreak/ fast heart rate), DIARRHOEA (Diarrhea), CHEST PAIN (Burning in a chest/ got constant burning in the chest), ERYTHEMA (Face and arms and chest turning red) and FEELING HOT (Skin feeling hot) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HEART RATE INCREASED (Fast heartbreak/ fast heart rate), DIARRHOEA (Diarrhea), CHEST PAIN (Burning in a chest/ got constant burning in the chest), ERYTHEMA (Face and arms and chest turning red), FEELING HOT (Skin feeling hot) and PYREXIA (Got a little of a fever 98. 7). At the time of the report, HEART RATE INCREASED (Fast heartbreak/ fast heart rate), DIARRHOEA (Diarrhea), CHEST PAIN (Burning in a chest/ got constant burning in the chest), ERYTHEMA (Face and arms and chest turning red), FEELING HOT (Skin feeling hot) and PYREXIA (Got a little of a fever 98. 7) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 98.7 (Inconclusive) little fever.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were provided.  No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 15-Jul-2021: Follow up information received included additional events.
Patient recieved flu shot at approximately 6pm Wed night, Thursday morning around 6 am she awoke with a headache, fever >103 and swollen lips and eyes. Mom gave her 200mg ibuprofen and 25mg diphenhydramine, patient fell back asleep and when she awoke 4 hours later her eyes and lips were not swollen, her headache was tolerable and fever was going down. Mom was going to continue ibuprofen every 6 hours and make sure she stays well hydrated and will follow up with her physician if the situation worsens or does not improve.
Patient received vaccine on 2/29/12. On 3/6/12, she developed a blister above her breast towards the center of her chest. On 3/7/12, a series of fluid-filled blisters had developed on one side of patient's neck/back. By 3/9/12 the rash had spread to the other side of her neck/back. The blisters were described as painful & itching.
COVID-19; COVID-19; This is a spontaneous report received from a contactable reporter (Consumer or other non HCP). The reporter is the patient.  A 33-year-old male patient received BNT162b2 (BNT162B2), as dose 3 (booster), single (Batch/Lot number: unknown) for COVID-19 immunisation; COVID-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for COVID-19 immunisation. The patient's relevant medical history included: "Attention deficit disorder" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant) all with onset 2022, outcome "unknown" and all described as "COVID-19". Therapeutic measures were taken as a result of drug ineffective, suspected COVID-19 with Paxlovid.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Approximately 1-2 days after second dose of Moderna, patient started to experience a rash, starting mainly at the feet, spread over entire body and has been getting worse since vaccination
This patient was given expired/BUD Moderna Covid Vaccine. Patient states they have not had any adverse reactions. This was a booster dose.
Approximately 24 hrs after child received her 4th DTaP, mom noticed redness at shot site (R deltoid). The following am 6/11/03 she noted more redness and now "lethargy." I examined child, not lethargic. T 100 deg F. 6x6cm area of erythema, warmth, induration around shot site. I felt it was more consistent, cellulitis and treated with Cephalexu.
Raised bump/rash developed 4/23 on left middle of back. Grew larger on 4/24 and 4/25. On 4/26, smaller bumps apread outward from inital weal. Visited dermatologist on 4/26 who diagnosed this as shingles. Will be treated with antiviral and steriods.
Pt reports a pimple over injection site one week after shot - went away one month later. Pain at injection site one day post shot. Never relieved - now pain with movement of shoulder in all directions, numbness in lt arm, pain awakened pt at night.
something odd happened/ some issues that don't happen all the time; pain in feet; a lot of difficulty walking; sick to stomach; gets very sick; suddenly get a fever; This spontaneous case was reported by an other health care professional and describes the occurrence of VACCINATION COMPLICATION (something odd happened/ some issues that don't happen all the time), PAIN IN EXTREMITY (pain in feet), GAIT DISTURBANCE (a lot of difficulty walking), GASTRIC DISORDER (sick to stomach) and ILLNESS (gets very sick) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (something odd happened/ some issues that don't happen all the time), PAIN IN EXTREMITY (pain in feet), GAIT DISTURBANCE (a lot of difficulty walking), GASTRIC DISORDER (sick to stomach), ILLNESS (gets very sick) and PYREXIA (suddenly get a fever). At the time of the report, VACCINATION COMPLICATION (something odd happened/ some issues that don't happen all the time), PAIN IN EXTREMITY (pain in feet), GAIT DISTURBANCE (a lot of difficulty walking), GASTRIC DISORDER (sick to stomach) and PYREXIA (suddenly get a fever) outcome was unknown and ILLNESS (gets very sick) was resolving.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medication was reported.    No treatment medications were reported.
12 hours after vaccine I had severe muscle pain, vomiting, severe headaches, and swollen arm, dizziness and blurry vision and that lasted about 24 hours. 2 days after the vaccine in the morning, I was at work and about 10 am I got very dizzy to the point of losing my balance dizzy. I drove home about a 1/2 hour later. I drove about 90 miles stopped at stop light and experienced vertigo, I went to ER. As, I got out of car, they sent a wheelchair and asked me my symptoms and they immediately told me I was having a stroke. They did cat scan and injected me with TPA. After that they then asked me when did the symptoms started, I told them after my vaccine. They admitted me into the ICU of hospital.
Swelling  and pain would move alternatively between wrist, knees, fingers and right toe and including the  injection site. After a period of five days the swelling settled in  wrists and knees, with reoccurring pain in the injection site. The swelling and pain persists  as of today's date of 7/9/2021.  Initial course of 20 mg Prednisone was prescribed by clinic on 6/18/2021 and a stronger course of 60mg for 3 days/40mg for 5 days and 20days for 5days by another MD on 6/21/2021. A rheumatologist referral has been made.  My  regular MD is taking over this case.
7/22/13 - Dad called states 7/18/13 patient presented with hive at site which now is swelling on (L) face and (L) eye, (R) hand and forearm, (L) neck and mid neck. BENADRYL being administered by parents.
Sore shoulder, severe diarrhea. Went 19 times in 1 night.
Cough; Sore throat; Abbott BinaxNOW:  Positive; Abbott BinaxNOW: Positive; Dose received:3; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 48 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 15Oct2021 (Lot number: FF8839) at the age of 48 years as dose 3 (booster), single for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: EP6955, Location of injection: Arm Left, Route of Administration: Intramuscular), administration date: 01Apr2021, when the patient was 48 years old, for COVID-19 immunization; Bnt162b2 (Dose Number: 2, Batch/Lot No: EP6955, Location of injection: Arm Left, Route of Administration: Intramuscular), administration date: 22Apr2021, when the patient was 48 years old, for COVID-19 immunization. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. It was unknown the patient receive any other vaccines within 4 weeks prior to the COVID vaccine. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset Dec2021, outcome "unknown" and all described as "Abbott BinaxNOW:  Positive"; IMMUNISATION (non-serious) with onset 15Oct2021, outcome "unknown", described as "Dose received:3"; COUGH (non-serious) with onset 25Dec2021 20:00, outcome "recovered" (25Dec2021), described as "Cough"; OROPHARYNGEAL PAIN (non-serious) with onset 25Dec2021 20:00, outcome "recovered" (25Dec2021), described as "Sore throat". Hospitalization was not prolonged. The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (Dec2021) positive, notes: Nasal Swab; (Dec2021) positive, notes: Nasal Swab. Therapeutic measures were not taken as a result of cough, oropharyngeal pain.  No follow-up attempts are possible. No further information is expected.
Urticaria; injection site was very itchy; dark red rash; dark red rash; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a nurse and describes the occurrence of URTICARIA (Urticaria) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced URTICARIA (Urticaria). At the time of the report, URTICARIA (Urticaria) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.   Topical antihistamines were recommended as treatment.
pt brought to ED (12/14/21)for worsening SOB; admitted to hospital; had prior hosp admission to outside hosp for COVID pneumonia (12/7/21);  SPO2 in 80S; placed on 5L O2 ; DNI/DNR; per previous report pt had been given dexamethasone and remdesivir; Coumadin for DVT; Lasix for volume overload; pt's condition deteriorated and she was made comfort measures only and would transition to inpatient hospice; pt continued to deteriorate and passed away in the hospital
This spontaneous report as received from a healthcare worker regarding an unspecified number of patients of unknown age. There was no information about concurrent condition and historical medication. On an unknown date the patients were vaccinated with improperly stored (Merck) VARIVAX lot # L034367, expiration date- 08-SEP-2017 (incorrect product storage). No adverse event was reported. The outcome of the event was unknown. Temperature/Time frame was 6F/10 hours. Possibly 4 doses were administered but healthcare worker was unable to confirm. There was none previous temperature excursion. No PQC (product quality complaint) was involved. Additional information has been requested.
Patient received vaccine around 2pm and by about 8pm was experiencing fever, chills, and sweating. Tthoughout the night she had bad sweats and high fever. Following morning patient states she passed out.
hot flashes; cold; clammy; up and down emotions; This non-serious case was reported by a consumer via call center representative and described the occurrence of hot flashes in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced hot flashes (Verbatim: hot flashes), cold (Verbatim: cold), clamminess (Verbatim: clammy) and emotional disorder (Verbatim: up and down emotions). The outcome of the hot flashes, cold, clamminess and emotional disorder were not resolved.   It was unknown if the reporter considered the hot flashes, cold, clamminess and emotional disorder to be related to Shingrix.     It was unknown if the company considered the hot flashes, cold, clamminess and emotional disorder to be related to Shingrix.   Additional Information: GSK Receipt Date: 21-JUL-2023 The patient self-reported this case. The reporter asked for Information about medication side effects as the patient had uncommon side effects. The patient was currently had up and down emotions and hot flashes, cold and clammy. The follow up would not possible as no contact details were available.
injection site has been itchy for a couple of days; there is a red bump size of a half dollar at the injection site; a bit of a heat at the injection site; A spontaneous report  was received from a consumer concerning a 79-year-old, female patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced injection site itchiness, a red bump (size of a half dollar) at the injection site and a bit of heat at the injection site.    The patient's medical history, as provided by the reporter, included thyroid and reflex. Concomitant medications reported includedthyroid and reflex medications.     On 12 Jan 2021, approximately 8 days prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Lot number: 012L20A ) intramuscularly in the left arm for prophylaxis of COVID-19 infection.     On 20 Dec 2021, the patient reported that the injection site was itching for a couple of days. On  the morning of 20 Jan 2021 she noticed a red bump size of a half dollar and felt a little heat there. Treatment for the eventswere not  included.   Action taken with mRNA-1273 in response to the events was not reported.     The outcome for the events, injection site itchiness, a red bump (size of a half dollar) and a bit of heat at the injection site were unknown.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
This spontaneous report was received from a pharmacist regarding a patient of unknown age and gender. Information on the concurrent condition, medical history and pertinent drug allergies of the patient were not reported. On 25-NOV-2015 at time- 23:08, the patient was vaccinated with improperly stored RECOMBIVAX HB lot # L016427 (expiry date, dose #, route, dose units and anatomical location were not specified). Concomitant medication was not reported. No adverse events were reported. The high temperature and low temperature at which the product was stored were 2.9 and 2.3 (units unspecified) respectively. There were no Product Quality Complaint (PQC) involved. This is one of several reports received from same reporter. Additional information has been requested.
Post vax, measles like rash on face and neck. Also severe swelling of face to point pt unable to open eyes.
3 bouts of ulcerative colitis; her B12 was over 2000; copper was 189.2; Folate 16.8; foamy spit; dry mouth; Breast pain in the right side; This is a spontaneous report received from a contactable consumer (patient). A 73-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE: Solution for injection, Lot number: unknown), via an unspecified route of administration in right shoulder muscle on 05Mar2021 at the age of 73 years old as SINGLE DOSE for COVID-19 immunization. Patient medical history included Hypothyroidism and high blood pressure. Concomitant medications included levothyroxine sodium (SYNTHRIOD), one half of 25 mcg tablet, once a day, taking the medication many years, it's been like 5 years for Hypothyroidism and hydrochlorothiazide 25mg 1 tablet daily for High blood pressure. On 18Mar2021, she had 3 bouts of ulcerative colitis, foamy spit, dry mouth, breast pain in the right side where she got first dose. The patient reported that, she had the Covid vaccine in March of 5th, she has some lab test drawn on 18th and copper level was extremely high and folate level was high too, plus she has been having Phony stiff in my mouth. It was also reported that, her B12 was high also it never been so high it never been 2000 and I haven't been taking b12 from quite a while, she wonders if this was shot related, had dry month and besides that she had three bout of colitis, ulcerative colitis attacks. The colitis, it started than and went through 24th about had 3 bouts of it 3 different days of terrible pain, started probably the 20th. It was also reported that, she is not eating a lot and not taking any supplements, her doctor told her to stop everything so that's what she did, usually she takes supplement. She said she is hesitant about taking the second dose. Caller wanted to know does the vaccine have copper in it and response. The patient supposed to get her 2nd one on Friday. On 18Mar2021, the patient had performed with lab tests and which included vitamin B12: 2000 pg/mL; Copper: 189.2 ug/dL and folate: 16.8 ng/mL. The patient did not take any treatment for events. There was no PQC involved. The outcome of the events was not recovered.   Information on Lot/Batch number was requested. cannot be obtained.
About a week after the YF injection, The patient said they woke up in the middle of the night with itching at the site of injection.  The site was itchy, red, and slightly swollen.  This persisted for 3 or 4 days and then resolved.
anxious; This spontaneous case was reported by a patient and describes the occurrence of ANXIETY (anxious) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes.    On 21-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ANXIETY (anxious). At the time of the report, ANXIETY (anxious) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient's concomitant medications included unspecified medication for diabetes.   No treatment information was provided.
Mild throat swelling; Mild tongue swelling; This spontaneous case was reported by a consumer and describes the occurrence of PHARYNGEAL SWELLING (Mild throat swelling) and SWOLLEN TONGUE (Mild tongue swelling) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced PHARYNGEAL SWELLING (Mild throat swelling) and SWOLLEN TONGUE (Mild tongue swelling). On 05-Mar-2021, PHARYNGEAL SWELLING (Mild throat swelling) and SWOLLEN TONGUE (Mild tongue swelling) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient stated that she is doing fine and is yet to take her second dose.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 02-May-2021: Follow-up received on 02-May-2021 contains non-significant information.
This was the booster shot I had visuals and my speech was affected for about 10 min while I was at work it took about 4 hours after the shot to show symptoms!
This spontaneous report as received from a physician refers to a pediatric patient of unknown age. On 03-OCT-2012, the patient experienced vaccinated with a dose of ZOSTAVAX (dose, route, lot number not reported) instead of VARIVAX (Merck) due to human error. No concomitant medications were reported. No adverse effect reported. This is one of several reports received from the same source. Additional information has been requested.
10/28/09 Rt side face felt numb-some trouble chewing. 10/29/09 Rt side face not working-rt eye slow to blink-rt side mouth droops when smiles-probable Bell's palsy.